Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: Mammon who wrote (888)	3/29/1999 10:27:00 AM
From: Wally	Respond to of 998

Mammon: In simple answer, Bios are cyclical performers and IMO, there time has come once again. I believe in part because many investors are looking beyond the Internet explosion and trying to read the next hot wave. Society's yearning for successful Biotechs is far greater than it's need for everything else combined. it's not an issue of having a faster computer chip, rather, it's an issue of life. or death. As was written in one of my personal investment Bibles, Financial Intelligence: "With one million baby-boomers turning 50 every day all over the World, we all know that health is going to be one of the most important industries of the new millennium. Everyone wants to live longer, look younger and enjoy life to the full in the best of all possible heath. Make no mistake. This is a major trend. A mega-trend that is unfolding as the World works to be richer and healthier. " I believe this comment is right on the money - my money anyway. While Biotechs have been cyclical and often poor performers their product has an undeniable and unequaled value to society. Of course a turn-around in the industry doesn't mean that you can't get burned anymore. The caution is in the picking, not in the purpose. There are a million unsuccessful Bios out there - some under-funded, some under-scienced - and some flat-out frauds. The trick is to either buy into larger, established bios or find small higher-risk companies with strong financial backing and strong ties to the Bio establishment. Newsletters like Financial Intelligence and other financial pundits have their own favorites. Obviously, always do your own DD. Wally